PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,686 | +177.8% | 4,750,000 | +111.1% | 0.44% | +219.7% |
Q1 2023 | $1,687 | -14.5% | 2,250,000 | 0.0% | 0.14% | -18.5% |
Q4 2022 | $1,974 | -99.9% | 2,250,000 | 0.0% | 0.17% | +46.1% |
Q3 2022 | $2,035,000 | +5.0% | 2,250,000 | 0.0% | 0.12% | -5.0% |
Q2 2022 | $1,939,000 | -3.7% | 2,250,000 | 0.0% | 0.12% | +18.6% |
Q1 2022 | $2,014,000 | -2.8% | 2,250,000 | 0.0% | 0.10% | -10.5% |
Q4 2021 | $2,071,000 | +2.7% | 2,250,000 | 0.0% | 0.11% | -1.7% |
Q3 2021 | $2,016,000 | +44.1% | 2,250,000 | +50.0% | 0.12% | +56.8% |
Q2 2021 | $1,399,000 | +2.0% | 1,500,000 | 0.0% | 0.07% | -11.9% |
Q1 2021 | $1,371,000 | +5.2% | 1,500,000 | 0.0% | 0.08% | -8.7% |
Q4 2020 | $1,303,000 | -4.2% | 1,500,000 | -25.0% | 0.09% | +187.5% |
Q2 2019 | $1,360,000 | – | 2,000,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PenderFund Capital Management Ltd. | 21,060,000 | $24,802,000 | 5.63% |
SILVERBACK ASSET MANAGEMENT LLC | 8,207,000 | $7,550,000 | 0.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,615,000 | $32,321,000 | 0.71% |
DeepCurrents Investment Group LLC | 11,621,000 | $10,631,000 | 0.33% |
AGF Investments LLC | 4,000,000 | $3,651,000 | 0.31% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 25,000,000 | $22,780,000,000 | 0.22% |
WATER ISLAND CAPITAL LLC | 2,250,000 | $2,071,000 | 0.11% |
L & S Advisors Inc | 935,000 | $853,000 | 0.09% |
Sculati Wealth Management, LLC | 200,000 | $183,000 | 0.09% |
PALISADE CAPITAL MANAGEMENT, LP | 3,192,000 | $2,909,000 | 0.06% |